Accure’s TiMES-Now assay tracks Covid-19 vaccine response, finds study
The TiMES platform was initially developed at the Harvard Medical School and Massachusetts General Hospital
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Jul 21
The TiMES platform was initially developed at the Harvard Medical School and Massachusetts General Hospital
15 Jul 21
The new easy-to-use saliva-based lateral flow test will help rapidly detect the SARS-CoV-2 antigen
15 Jul 21
The new Cx20 technology will help doctors determine whether the colorectal lesions are neoplastic or non-neoplastic
15 Jul 21
. The Aptima SARS-CoV-2 assay is also CE-marked for use with nasopharyngeal and nasal swabs as well as…
15 Jul 21
CoapTech is a Baltimore-based medical device company commercializing a new platform called the PUMA System
14 Jul 21
The OmniTom Elite with PCD will be piloted to monitor post-trauma and post-surgical patients
14 Jul 21
With the new funding, Aidoc is enabled to expand its cross-speciality AI platform for medical imaging
Clinical Trial Investigates Company's Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention
14 Jul 21
Acquisition enriches WCG's scientific and regulatory capabilities with comprehensive services ensuring quality and validity of clinical trial results
13 Jul 21
SpectraLIT - Spectral Instant Test is claimed to be the world's fastest Covid-19 test, which delivers results in…